Literature DB >> 23605851

Trichomoniasis and HIV interactions: a review.

Patricia Kissinger1, Alys Adamski.   

Abstract

OBJECTIVE: To discuss the epidemiology of Trichomonas vaginalis (TV) and HIV co-infections, the role of TV in acquisition and transmission of HIV, special treatment considerations for TV among women with HIV and the prevention of TV among HIV-infected persons.
DESIGN: Systematic review. DATA SOURCE: Review of literature of EMBASE and PubMed databases from January 1990 to February 2013. Search keywords included TV, HIV co-infections, HIV acquisition, HIV transmission, HIV shedding, TV treatment, HIV and couples studies. REVIEW
METHOD: We included studies of any design that contained the selected search words and were published during the specified time frame. We then searched the reference lists of included papers for additional papers and included these when relevant.
RESULTS: There is strong evidence that TV increases both transmission and acquisition of HIV among women, and that successful treatment for TV can reduce HIV genital shedding. Single dose metronidazole (MTZ) should no longer be used for HIV+ women with TV given the high rates of asymptomatic bacterial vaginosis co-infections and other factors that may render MTZ less effective in HIV+ women. Prevention of TV among HIV+ persons is similar to among HIV, including promotion of condoms as well as regular screening and prompt treatment. There may be a role for expedited partner treatment for the prevention of repeat infections, but most repeat infections are clinical treatment failures. Diligence in screening and treating TV among both HIV- susceptible and HIV+ persons is an important public health strategy.

Entities:  

Keywords:  HIV; PUBLIC HEALTH; TRANSMISSION DYNAMICS; TREATMENT; TRICHOMONAS

Mesh:

Year:  2013        PMID: 23605851      PMCID: PMC3748151          DOI: 10.1136/sextrans-2012-051005

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  74 in total

1.  Determinants of HIV-1 shedding in the genital tract of women.

Authors:  A Kovacs; S S Wasserman; D Burns; D J Wright; J Cohn; A Landay; K Weber; M Cohen; A Levine; H Minkoff; P Miotti; J Palefsky; M Young; P Reichelderfer
Journal:  Lancet       Date:  2001-11-10       Impact factor: 79.321

2.  The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1.

Authors:  C C Wang; R S McClelland; M Reilly; J Overbaugh; S R Emery; K Mandaliya; B Chohan; J Ndinya-Achola; J Bwayo; J K Kreiss
Journal:  J Infect Dis       Date:  2001-02-28       Impact factor: 5.226

Review 3.  A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much really is known?

Authors:  J A Røttingen; D W Cameron; G P Garnett
Journal:  Sex Transm Dis       Date:  2001-10       Impact factor: 2.830

4.  Prevalence, incidence, and persistence or recurrence of trichomoniasis among human immunodeficiency virus (HIV)-positive women and among HIV-negative women at high risk for HIV infection.

Authors:  Susan Cu-Uvin; Hyejin Ko; Denise J Jamieson; Joseph W Hogan; Paula Schuman; Jean Anderson; Robert S Klein
Journal:  Clin Infect Dis       Date:  2002-04-22       Impact factor: 9.079

5.  High prevalence of trichomoniasis in rural men in Mwanza, Tanzania: results from a population based study.

Authors:  D Watson-Jones; K Mugeye; P Mayaud; L Ndeki; J Todd; F Mosha; B West; B Cleophas-Frisch; H Grosskurth; M Laga; R Hayes; D Mabey; A Buvé
Journal:  Sex Transm Infect       Date:  2000-10       Impact factor: 3.519

6.  Effect of interventions to control sexually transmitted disease on the incidence of HIV infection in female sex workers.

Authors:  P D Ghys; M O Diallo; V Ettiègne-Traoré; G A Satten; C K Anoma; C Maurice; J C Kadjo; I M Coulibaly; S Z Wiktor; A E Greenberg; M Laga
Journal:  AIDS       Date:  2001-07-27       Impact factor: 4.177

7.  Factors associated with nucleic acids related to human immunodeficiency virus type 1 in cervico-vaginal secretions.

Authors:  A Spinillo; M Debiaggi; F Zara; R Maserati; F Polatti; A De Santolo
Journal:  BJOG       Date:  2001-06       Impact factor: 6.531

Review 8.  Trichomonas vaginalis, HIV, and African-Americans.

Authors:  F Sorvillo; L Smith; P Kerndt; L Ash
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883

9.  Addition of treatment for trichomoniasis to syndromic management of urethritis in Malawi: a randomized clinical trial.

Authors:  Matthew A Price; Dickman Zimba; Irving F Hoffman; S Cornelia Kaydos-Daniels; William C Miller; Francis Martinson; David Chilongozi; Ester Kip; Esnath Msowoya; Marcia M Hobbs; Peter N Kazembe; Myron S Cohen
Journal:  Sex Transm Dis       Date:  2003-06       Impact factor: 2.830

10.  Influence of HIV-1 coinfection on effective management of abnormal vaginal discharge.

Authors:  Prashini Moodley; David Wilkinson; Cathy Connolly; A Willem Sturm
Journal:  Sex Transm Dis       Date:  2003-01       Impact factor: 2.830

View more
  68 in total

1.  Abuse Impedes Prevention: The Intersection of Intimate Partner Violence and HIV/STI Risk Among Young African American Women.

Authors:  Puja Seth; Gina M Wingood; LaShun S Robinson; Jerris L Raiford; Ralph J DiClemente
Journal:  AIDS Behav       Date:  2015-08

2.  Diagnostic rates differ on the basis of the number of read days with the use of the InPouch culture system for Trichomonas vaginalis screening.

Authors:  Charles A Rivers; Christina A Muzny; Jane R Schwebke
Journal:  J Clin Microbiol       Date:  2013-09-04       Impact factor: 5.948

3.  Trichomonas vaginalis and Human Immunodeficiency Virus Coinfection Among Women Under Community Supervision: A Call for Expanded T. vaginalis Screening.

Authors:  Alissa Davis; Anindita Dasgupta; Dawn Goddard-Eckrich; Nabila El-Bassel
Journal:  Sex Transm Dis       Date:  2016-10       Impact factor: 2.830

4.  Anti-Trichomonas vaginalis activity of chalcone and amino-analogues.

Authors:  Márcia Rodrigues Trein; Lígia Rodrigues E Oliveira; Graziela Vargas Rigo; Mayara Aparecida Rocha Garcia; Brenda Petro-Silveira; Danielle da Silva Trentin; Alexandre José Macedo; Luis Octávio Regasini; Tiana Tasca
Journal:  Parasitol Res       Date:  2018-12-07       Impact factor: 2.289

5.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

Review 6.  Oral pre-exposure prophylaxis (PrEP) for prevention of HIV in serodiscordant heterosexual couples in the United States: opportunities and challenges.

Authors:  James M McMahon; Julie E Myers; Ann E Kurth; Stephanie E Cohen; Sharon B Mannheimer; Janie Simmons; Enrique R Pouget; Nicole Trabold; Jessica E Haberer
Journal:  AIDS Patient Care STDS       Date:  2014-07-21       Impact factor: 5.078

7.  Optimal Timing for Trichomonas vaginalis Test of Cure Using Nucleic Acid Amplification Testing.

Authors:  Megan Clare Craig-Kuhn; Charleigh Granade; Christina A Muzny; Barbara Van Der Pol; Rebecca Lillis; Stephanie N Taylor; Norine Schmidt; David H Martin; Patricia Kissinger
Journal:  Sex Transm Dis       Date:  2019-05       Impact factor: 2.830

8.  Prevalence and Correlates of Trichomonas vaginalis Infection Among Men and Women in the United States.

Authors:  Eshan U Patel; Charlotte A Gaydos; Zoe R Packman; Thomas C Quinn; Aaron A R Tobian
Journal:  Clin Infect Dis       Date:  2018-07-02       Impact factor: 9.079

Review 9.  A Comprehensive Review of Aminochalcones.

Authors:  Rimsha Irfan; Shikufa Mousavi; Meshari Alazmi; Rahman Shah Zaib Saleem
Journal:  Molecules       Date:  2020-11-17       Impact factor: 4.411

10.  Rapid Diagnosis of Trichomonas vaginalis by Testing Vaginal Swabs in an Isothermal Helicase-Dependent AmpliVue Assay.

Authors:  Charlotte A Gaydos; Marcia Hobbs; Jeanne Marrazzo; Jane Schwebke; Jenell S Coleman; Billie Masek; Laura Dize; Dan Jang; Jenny Li; Max Chernesky
Journal:  Sex Transm Dis       Date:  2016-06       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.